LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Long-Term Deferred Tax (2015 - 2026)

LivaNova's (LIVN) quarterly Long-Term Deferred Tax came in at $198.7 million in Q2 2026, up 80.99% year-over-year from $109.8 million in Q2 2025, and up 80.98% quarter-over-quarter from $109.8 million in Q1 2026.

Analysis

LivaNova (LIVN) Long-Term Deferred Tax (2015 - 2026) Analysis & Trends

LivaNova has disclosed Long-Term Deferred Tax across 12 years of filings, most recently posting $198.7 million for Q2 2026.

  • In Q2 2026, Long-Term Deferred Tax rose 80.99% year-over-year to $198.7 million; the TTM figure through Jun 2026 stood at $198.7 million (up 80.99% YoY), while the FY2025 annual figure was $111.0 million, down 0.78% from the prior year.
  • Long-Term Deferred Tax came in at $198.7 million for Q2 2026 at LivaNova, up from $109.8 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $198.7 million in Q2 2026 to a low of $1.4 million in Q4 2022.
  • Average Long-Term Deferred Tax over 5 years is $73.7 million, with a median of $109.6 million recorded in 2025.
  • The largest YoY upside for Long-Term Deferred Tax was 8488.01% in 2023 against a maximum downside of 43.2% in 2023.
  • Over 5 years, Long-Term Deferred Tax stood at $1.4 million in 2022, then soared by 8488.01% to $118.9 million in 2023, then fell by 5.89% to $111.9 million in 2024, then slipped by 0.78% to $111.0 million in 2025, then jumped by 79.08% to $198.7 million in 2026.
  • Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $198.7 million in Q2 2026, $109.8 million in Q1 2026, and $111.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 198.75 Mn
Mar 31, 2026 109.82 Mn
Dec 31, 2025 110.98 Mn
Sep 30, 2025 107.31 Mn
Jun 30, 2025 109.81 Mn
Mar 31, 2025 109.46 Mn
Dec 31, 2024 111.86 Mn
Sep 30, 2024 109.99 Mn
Jun 30, 2024 113.01 Mn
Mar 31, 2024 113.69 Mn
Dec 31, 2023 118.86 Mn
Sep 30, 2023 1.51 Mn
Jun 30, 2023 2.11 Mn
Mar 31, 2023 1.53 Mn
Dec 31, 2022 1.38 Mn
Sep 30, 2022 1.42 Mn
Jun 30, 2022 2.42 Mn
Mar 31, 2022 2.70 Mn
Dec 31, 2021 2.20 Mn
Sep 30, 2021 2.01 Mn